Contego Medical Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Series E

  • Latest Deal Amount
  • $23M

  • Investors
  • 7

Contego Medical General Information

Description

Developer of an integrated embolic protection technology designed to address needs in peripheral and cardiovascular procedures. The company's technology is an integration of embolic protection onto the same catheter as the treatment portion, enabling clients to deliver treatment simplicity and safety during cardiovascular procedures.

Contact Information

Formerly Known As
Contego Medical LLC
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 3801 Lake Boone Trail
  • Suite 100
  • Raleigh, NC 27607
  • United States
+1 (888) 000-0000

Contego Medical Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Contego Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series E) 19-Apr-2023 $23M 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series D) 12-Apr-2022 000.00 000.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 08-Jun-2020 000.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series B) 17-Apr-2015 00.00 00.000 000.00 Completed Generating Revenue
2. Debt - General 11-Feb-2014 $250K $1.75M Completed Generating Revenue
1. Early Stage VC (Series A1) 08-May-2012 $1.5M $1.5M 000.00 Completed Startup
To view Contego Medical’s complete valuation and funding history, request access »

Contego Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series D 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C-2 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series C-1 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A1 937,472 $0.001000 8% $1.94 $1.94 1x $1.94 2.16%
Series A 369,000 $0.001000 8% $1.35 $1.35 1x $1.35 0.85%
To view Contego Medical’s complete cap table history, request access »

Contego Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an integrated embolic protection technology designed to address needs in peripheral and cardiovascular proc
Surgical Devices
Raleigh, NC
37 As of 2023
000.00
0000 0000-00-00
00000000000 000.00

000000

do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
00000000 0000000
Santa Cruz, CA
00 As of 0000
0000
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Contego Medical Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000000 Venture Capital-Backed Santa Cruz, CA 00 0000 00000000000 0000
You’re viewing 1 of 1 competitors. Get the full list »

Contego Medical Patents

Contego Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230233818-A1 Thrombectomy and aspiration system and methods of use Pending 27-Jan-2022 000000000 0
US-20220338887-A1 Thrombus aspiration system and methods for controlling blood loss Active 27-Apr-2021 0000000000 00
US-20220339338-A1 Thrombus aspiration system and methods for controlling blood loss Active 27-Apr-2021 0000000000 00
US-20220339339-A1 Thrombus aspiration system and methods for controlling blood loss Active 27-Apr-2021 0000000000 00
US-11679194-B2 Thrombus aspiration system and methods for controlling blood loss Active 27-Apr-2021 A61M1/74 000
To view Contego Medical’s complete patent history, request access »

Contego Medical Executive Team (9)

Name Title Board Seat Contact Info
Ravish Sachar MD Founder, Chief Executive Officer & Chairman
David Stern President & Chief Operating Officer
Nathalie Greene Chief Financial Officer
Steve MacKinnon Chief Commercial Officer
Elizabeth Saylors Vice President of Compliance & Scientific Affairs
You’re viewing 5 of 9 executive team members. Get the full list »

Contego Medical Board Members (10)

Name Representing Role Since
Douglas Reed MD Hatteras Venture Partners Board Member 000 0000
Hanson Gifford III Self Board Member 000 0000
Jay Yadav Self Board Member 000 0000
Joyce Erony Self Board Member 000 0000
Marvin Woodall Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Contego Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Contego Medical Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Amzak Health Venture Capital Minority 000 0000 000000 0
Medtronic Corporation Minority 000 0000 000000 0
Tidewater Investment Company PE/Buyout Minority 000 0000 000000 0
Curi Limited Partner Minority 000 0000 000000 0
Hatteras Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »